"Riluzole" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Descriptor ID |
D019782
|
MeSH Number(s) |
D02.886.675.651 D03.383.129.708.089.611 D03.633.100.185.611
|
Concept/Terms |
Riluzole- Riluzole
- 2-Amino-6-trifluoromethoxybenzothiazole
- 2 Amino 6 trifluoromethoxybenzothiazole
|
Below are MeSH descriptors whose meaning is more general than "Riluzole".
Below are MeSH descriptors whose meaning is more specific than "Riluzole".
This graph shows the total number of publications written about "Riluzole" by people in this website by year, and whether "Riluzole" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2017 | 1 | 0 | 1 |
2023 | 1 | 0 | 1 |
2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Riluzole" by people in Profiles.
-
Fehlings MG, Pedro KM, Alvi MA, Badhiwala JH, Ahn H, Farhadi HF, Shaffrey CI, Nassr A, Mummaneni P, Arnold PM, Jacobs WB, Riew KD, Kelly M, Brodke DS, Vaccaro AR, Hilibrand AS, Wilson J, Harrop JS, Yoon ST, Kim KD, Fourney DR, Santaguida C, Massicotte EM, Huang P. Riluzole for Degenerative Cervical Myelopathy: A Secondary Analysis of the CSM-PROTECT Trial. JAMA Netw Open. 2024 Jun 03; 7(6):e2415643.
-
Fehlings MG, Neal CJ, Hejrati N, Harrop JS, Toups EG, Guest JD. An Introduction to the North American Clinical Trials Network for Spinal Cord Injury Special Edition: Reflections on Accomplishments and a Look to the Future. J Neurotrauma. 2023 09; 40(17-18):1811-1816.
-
Ilieva H, Maragakis NJ. Motoneuron Disease: Clinical. Adv Neurobiol. 2017; 15:191-210.